In accordance with proteomic data (Supplementary Table 1), immunoblotting analysis revealed a slight decrease in olfactory Vim protein levels in initial and advanced AD stages, and a down-regulation of Phb2 protein levels in intermediate and advanced AD stages with respect to controls (Fig. 7a). This evidence concerns the gene PHB2 and Alzheimer disease.